Launch Oregon
1720 E. 13th Ave., Suite 410, Eugene, OR, 97403, United States
Overview
Launch Oregon brings together innovators, investors, and partners to transfer ideas from the lab to the real world. Launch Oregon provides the opportunity to collaborate with UO innovators across multiple programs and colleges, receive best practices guidance from the Industry, innovation, and translation (IIT) unit, and receive mentorship from industry experts through the IIT's translational opportunity program.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Venture Capital
Investment portfolio
- InVivo Biosystems
Participated · Equity · Jan 2024
InVivo Biosystems provides CRISPR genome editing and end-to-end preclinical services, creating custom genome-edited C. elegans and zebrafish models and delivering in-vivo analytical data to support early-stage drug development. The company leverages extensive intellectual property in genetically modified organisms to accelerate target identification and compound screening with rapid turnaround and affordability. In January 2024 it announced a $3M new investment to advance commercialization of its CRISPR capabilities. Recent technology validation includes new patents, an exclusive license (MIC-Drop) from the University of Utah for a high-throughput CRISPR microfluidic approach, and an NIH Fast-Track SBIR award. The NIH grant — $2.8M — will fund development of an AI-based automated zebrafish monitoring system to enable automated deep phenotyping. The appointment of C. Palani Palaniappan, Ph.D., as board chairman was announced alongside the financing to support commercialization and corporate strategy in 2024.
Team
No current team members are available.